Publications

Planning to submit a paper?

If you are planning to submit a paper, please consult the rules for acknowledging SHM and the Ministry of Health, Welfare and Sport and for a copy of the standard ATHENA acknowledgement text. 

 

Latest scientific publications

2018 2017 20162015 | 2014 | 2013 | 2012 | 2011 | 2010-2006 | 2005-2001 | 2000-1996 |

Here is a list of the latest scientific publications published by the clinical research groups connected to ATHENA/SHM.

 

2017 update to the HIV-TRePS system: The development of new computational models to predict HIV treatment outcomes, with or without a genotype with enhanced usability for low-income settings
Revell AD, Wang D, Perez-Elias M-J,Wood R Cogill D, Tempelman H,Hamers RL, Reiss P, van Sighem A, Rehm CA, Pozniak A, Montaner JSG, Lane HC & Larder BA on behalf of the RDI study group.
Journal of Antimicrobial Chemotherapy Abstract

Associations between serum albumin and serious non-AIDS events among people living with HIV
Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, Monforte AD, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study group.
AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001900. [Epub ahead of print] Abstract

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data
Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Croucher NJ, Hall M, Hillebregt M, Ong SH, Ratmann O, Albert J, Bannert N, Fellay J, Fransen K, Gourlay A, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos R, Laeyendecker O, Liitsola K, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Cornelissen M, Kellam P, Reiss P, Fraser C; BEEHIVE Collaboration.
Virus Evol. 2018 May 18;4(1):vey007. doi: 10.1093/ve/vey007. eCollection 2018 Jan. Abstract

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4:CD8 ratio: ART Cohort Collaboration (ART-CC) Study
Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, Monforte AD, Smith C, Cavassini M, Saag M, Sterling TR, Sterne JAC.
AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848. [Epub ahead of print] Abstract

Body mass index and the risk of serious non-AIDS events and all cause mortality in treated HIV-positive individuals: D: A: D cohort analysis
Achhra AC, Sabin C, Ryom L, Hatleberg C, d'Aminio Monforte A, Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D study group.
J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097 Abstract

The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics
De Francesco D, Wit FW, Cole JH, Kootstra NA, Winston A, Sabin CA, Underwood J, van Zoest RA, Schouten J, Kooij KW, Prins M, Guaraldi G, Caan MWA, Burger D, Franceschi C, Libert C, Bürkle A, Reiss P; COmorBidity in Relation to AIDS (COBRA) collaboration.
PLoS One. 2018 Mar 29;13(3):e0191791. doi: 10.1371/journal.pone.0191791. eCollection 2018 Abstract

HIV-1 status is independently associated with decreased erectile function among middle-aged men who have sex with men in the era of cART
Dijkstra M, Van Lunsen RHW, Kooij KW, Davidovich U, Van Zoest RA, Wit FWMN, Prins M, Reiss P, Loeff MFSV; AGEhIV Cohort Study Group.
AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001800. [Epub ahead of print] Abstract

The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people
Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.
HIV Med. 2018 Feb;19(2):90-101. doi: 10.1111/hiv.12546. Epub 2017 Aug 31. Abstract

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens
Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group.
HIV Med. 2018 Feb;19(2):102-117. doi: 10.1111/hiv.12557. Epub 2017 Oct 6. Abstract

Abacavir use and risk of recurrent myocardial infarction
Sabin CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, Pradier C, El-Sadr W, Kirk O, Weber R, Phillips AN, Mocroft A, Bonnet F, Law M, de Wit S, Reiss P, Lundgren JD; D:A:D Study Group.
AIDS. 2018 Jan 2;32(1):79-88. doi: 10.1097/QAD.0000000000001666. Abstract

Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection
Young J, Smith C, Teira R, Reiss P, Jarrín Vera I, Crane H, Miro JM, D'Arminio Monforte A, Saag M, Zangerle R, Bucher HC; Antiretroviral Therapy Cohort Collaboration (ART-CC).
HIV Med. 2018 Feb;19(2):132-142. doi: 10.1111/hiv.12562. Epub 2017 Nov 6. Abstract

Global trends in CD4 count at start of antiretroviral treatment: collaborative study of treatment programs
IeDEA and COHERE Cohort Collaborations
Clin Infect Dis. 2018 Jan 25. doi: 10.1093/cid/cix915. [Epub ahead of print] Abstract

Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age
Snijdewind IJM, Smit C, Godfried MH, Bakker R, Nellen JFJB, Jaddoe VWV, van Leeuwen E, Reiss P, Steegers EAP, van der Ende ME.
PLoS One. 2018 Jan 19;13(1):e0191389. doi: 10.1371/journal.pone.0191389. eCollection 2018. Abstract

Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K; for CASCADE Collaboration in EuroCoord.
AIDS. 2018 Jan 14;32(2):161-169. doi: 10.1097/QAD.0000000000001689. Abstract

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD; EuroSIDA Study.
AIDS. 2018 Jan 14;32(2):205-215. doi: 10.1097/QAD.0000000000001684. Abstract

No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project.
Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit FWNM, Mutsaerts HJMM, Leech R, Geurtsen GJ, Portegies P, Majoie CBLM, Schim van der Loeff MF, Sabin CA, Reiss P, Winston A, Sharp DJ; COBRA collaboration.
Clin Infect Dis. 2018 Jan 4. doi: 10.1093/cid/cix1124. [Epub ahead of print] Abstract

Increased non-AIDS mortality among persons with AIDS defining events after antiretroviral therapy initiation
Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JAC, Sterling TR, for the Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators
J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031. Abstract

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases.
Engelhard EAN, Smit C, van Dijk PR, Kuijper TM, Wermeling PR, Weel AE, de Boer MR, Brinkman K, Geerlings SE, Nieuwkerk PT.
AIDS. 2018 Jan 2;32(1):103-112. doi: 10.1097/QAD.0000000000001672. Abstract

Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions
Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, Gogos C, Abgrall S, Costagliola D, Meyer L, Seng R, van Sighem A, Reiss P, Muga R, Hoyos SP, Braun D, Hauser C, Barrufet P, Leyes M, Tate J, Justice A, Hernán MA.
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):102-109. doi: 10.1097/QAI.0000000000001562. Abstract

 
 

Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) makes an essential contribution to healthcare for HIV-positive people in the Netherlands.  Working with all recognised HIV treatment centres in the Netherlands, SHM systematically collects coded medical data from all registered HIV patients. SHM uses these data to produce centre-specific reports that allow HIV treatment centres to optimise their patient care and obtain formal certification. SHM’s data also form the basis for the yearly HIV monitoring report and are used in HIV-related research in the Netherlands and internationally. The outcome of SHM’s research provides tangible input into HIV care and prevention polices in the Netherlands.

Visiting address

Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam
The Netherlands

Postal address

Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam
The Netherlands

© SHM Monitoring Foundation |Disclaimer|Colofon